University of Florida-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Florida - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013569
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Florida (UF) is an educational institute that offers undergraduate, graduate and distance learning programs. The institute offers educational programs in areas of agricultural, business administration, journalism and communications, law, dentistry, arts and sciences, medicine, nursing, engineering, pharmacy, fine arts and veterinary medicine, among others. It also offers advertising, marketing and public relations and human services, among others. The institute conducts research in brain related problems, aging problems, oncology, genetics, pathogens and gene therapy, among others. UF is headquartered in Gainesville, Florida, the US.

University of Florida – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Florida, Medical Devices Deals, 2011 to YTD 2017 9
University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Florida, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Colorescience Raises US$10 Million In Series A Financing 11
Partnerships 12
Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 12
CRISPR Therapeutics to Enter into Agreement with University of Florid 13
Prosolia Enters into Research Agreement with University of Florida 14
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 15
IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 16
Licensing Agreements 17
DNAtrix Enters into Licensing Agreement with University of Florida 17
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 18
NuVax Therapeutics Enters Into Licensing Agreement With University of Florida 19
Asset Transactions 20
Oceanyx Pharma Acquires Rights to Marine Natural-Product Chemistry Library from University of Florida 20
University of Florida – Key Competitors 21
University of Florida – Key Employees 22
University of Florida – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Government and Public Interest 24
Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 24
Sep 26, 2017: Study outlines precancerous treatment of anal lesions 27
Aug 29, 2017: Morehouse School of Medicine Joins the NIH All of Us Research Consortium 28
Jul 26, 2017: Waterlogged brain region helps scientists gauge damage caused by Parkinson’s disease 29
Oct 17, 2016: FDA awards 21 grants to stimulate product development for rare diseases 30
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 32
Jul 28, 2016: Bayer Recognizes Research in Hemophilia and Bleeding Disorders for Fourteenth Straight Year 34
Mar 24, 2016: Hyundai Hope On Wheels Unveils $13 Million Commitment To Childhood Cancer In 2016, Marks More Than $115 Million Of Funding To Date 35
Mar 24, 2016: Hyundai Hope On Wheels Announces Recipients Of $1 Million Quantum Grant To Fund Transformational Pediatric Cancer Research 36
Feb 12, 2016: Researchers present inner workings of Ebola vaccine trial 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
University of Florida, Pharmaceuticals & Healthcare, Key Facts 2
University of Florida, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Florida, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Florida, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Florida, Deals By Therapy Area, 2011 to YTD 2017 8
University of Florida, Medical Devices Deals, 2011 to YTD 2017 9
University of Florida, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Colorescience Raises US$10 Million In Series A Financing 11
Prometheon Enters into Licensing Agreement with University of Florida Research Foundation 12
CRISPR Therapeutics to Enter into Agreement with University of Florid 13
Prosolia Enters into Research Agreement with University of Florida 14
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 15
IntelliCell BioSciences Enters Into Research Agreement With University of Florida For Stem Cell And Tissue Repair 16
DNAtrix Enters into Licensing Agreement with University of Florida 17
Sun BioPharma Enters into Licensing Agreement with University of Florida Research Foundation 18
NuVax Therapeutics Enters Into Licensing Agreement With University of Florida 19
Oceanyx Pharma Acquires Rights to Marine Natural-Product Chemistry Library from University of Florida 20
University of Florida, Key Competitors 21
University of Florida, Key Employees 22
University of Florida, Subsidiaries 23

★海外企業調査レポート[University of Florida-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroLogica Corp-医療機器分野:企業M&A・提携分析
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Exosome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • First Philippine Holdings Corp (FPH):企業の財務・戦略的SWOT分析
    First Philippine Holdings Corp (FPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Infinera Corp:企業の戦略・SWOT・財務分析
    Infinera Corp - Strategy, SWOT and Corporate Finance Report Summary Infinera Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sojitz Corporation:企業の戦略・SWOT・財務分析
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • One Way Liver SL-製薬・医療分野:企業M&A・提携分析
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagn …
  • Tubacero S. de RL de CV:企業の戦略・SWOT・財務分析
    Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report Summary Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sinopac Financial Holdings Company Limited:企業の戦略・SWOT・財務分析
    Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Repower AG:電力:M&Aディール及び事業提携情報
    Summary Repower AG (Repower), formerly Ratia Energie AG is an energy company that produces, transmits and distributes electricity. The company's services include trading, market access, and sales support services. It generates electric energy from hydropower, wind power plants, and combined-cycle ga …
  • Gardner Denver Holdings, Inc. (GDI):企業の財務・戦略的SWOT分析
    Gardner Denver Holdings, Inc. (GDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Adani Enterprises Ltd (ADANIENT)
    Adani Enterprises Ltd (ADANIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • DBK Pharmaceutical:製薬・医療:M&Aディール及び事業提携情報
    Summary DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The company’s pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Pancake House, Inc.:企業の戦略・SWOT・財務情報
    Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pellegrini S.p.A.:企業の戦略・SWOT・財務分析
    Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Miltenyi Biotec GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company that offers biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company offers sample preparation, cell separation, flow cytometry, cell culture and stimulati …
  • Adris grupa d.d.:企業の戦略・SWOT・財務情報
    Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report Summary Adris grupa d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Eastern Platinum Limited:企業の戦略・SWOT・財務情報
    Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Micron Technology Inc:戦略・SWOT・企業財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆